nothing wrong with spending R&D and sure capitalise if appropriate......my point was 1H21 looks somewhat diff to prior halves (not only in the total amount, but also the % capitalised).
Again, could be perfectly appropriate, but just wondering (aloud) why R&D suddenly spiked when new business has dropped (& project fees associated with new implementation has fallen).....perhaps nothing, and the company had the bandwidth in this downtime to accelerate software development
Ann: Investor Presentation, page-4
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BVS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.38 |
Change
0.025(1.85%) |
Mkt cap ! $616.4M | |||
| Open | High | Low | Value | Volume |
| $1.36 | $1.39 | $1.35 | $784.5K | 573.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2836 | $1.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.38 | 7728 | 3 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| BVS (ASX) Chart |